Latest Insider Transactions at Molina Healthcare, Inc. (MOH)
This section provides a real-time view of insider transactions for Molina Healthcare, Inc. (MOH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MOLINA HEALTHCARE, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MOLINA HEALTHCARE, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2024
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
711
-2.77%
|
$273,024
$384.25 P/Share
|
|
Feb 12
2024
|
Mark Lowell Keim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-5.54%
|
$5,790,000
$386.29 P/Share
|
|
Jan 01
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
152
+2.35%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+6.7%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
152
+0.78%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
152
+0.88%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+1.16%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+0.92%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+4.1%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+2.62%
|
$54,872
$361.31 P/Share
|
|
Nov 29
2023
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
335
-1.94%
|
$119,930
$358.0 P/Share
|
|
Nov 21
2023
|
Joseph M Zubretsky President & CEO |
SELL
Bona fide gift
|
Direct |
5,700
-1.73%
|
-
|
|
Oct 30
2023
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
1,134
-5.55%
|
$368,550
$325.96 P/Share
|
|
Oct 01
2023
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
168
+0.97%
|
$54,936
$327.89 P/Share
|
|
Oct 01
2023
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+1.3%
|
$54,936
$327.89 P/Share
|
|
Oct 01
2023
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+1.03%
|
$54,936
$327.89 P/Share
|
|
Oct 01
2023
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
168
+2.65%
|
$54,936
$327.89 P/Share
|
|
Oct 01
2023
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+4.71%
|
$54,936
$327.89 P/Share
|
|
Oct 01
2023
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+2.96%
|
$54,936
$327.89 P/Share
|
|
Oct 01
2023
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
168
+7.87%
|
$54,936
$327.89 P/Share
|
|
Oct 01
2023
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
168
+0.82%
|
$54,936
$327.89 P/Share
|
|
Sep 13
2023
|
Maurice Hebert Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
692
-7.51%
|
$226,976
$328.15 P/Share
|
|
Aug 07
2023
|
Marc Russo EVP, Health Plans |
SELL
Open market or private sale
|
Direct |
2,523
-6.37%
|
$787,176
$312.72 P/Share
|
|
Aug 04
2023
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
723
-3.44%
|
$217,623
$301.25 P/Share
|
|
Aug 01
2023
|
Jeff D. Barlow Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,500
-8.42%
|
$3,775,000
$302.79 P/Share
|
|
Jul 31
2023
|
Barbara L Brasier Director |
SELL
Open market or private sale
|
Direct |
1,500
-31.7%
|
$454,500
$303.89 P/Share
|
|
Jul 01
2023
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
183
+3.32%
|
$55,083
$301.24 P/Share
|
|
Jul 01
2023
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
183
+3.72%
|
$55,083
$301.24 P/Share
|
|
Jul 01
2023
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
183
+1.43%
|
$55,083
$301.24 P/Share
|
|
Jul 01
2023
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
183
+1.13%
|
$55,083
$301.24 P/Share
|
|
Jul 01
2023
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
183
+1.06%
|
$55,083
$301.24 P/Share
|
|
Jul 01
2023
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
183
+0.86%
|
$55,083
$301.24 P/Share
|
|
Jul 01
2023
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
183
+9.24%
|
$55,083
$301.24 P/Share
|
|
Jul 01
2023
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
183
+2.96%
|
$55,083
$301.24 P/Share
|
|
Jun 30
2023
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.1%
|
$22,575
$301.24 P/Share
|
|
Jun 30
2023
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.14%
|
$22,575
$301.24 P/Share
|
|
Apr 01
2023
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
206
+1.28%
|
$55,002
$267.49 P/Share
|
|
Apr 01
2023
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
206
+1.63%
|
$55,002
$267.49 P/Share
|
|
Apr 01
2023
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
206
+4.33%
|
$55,002
$267.49 P/Share
|
|
Apr 01
2023
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
206
+11.31%
|
$55,002
$267.49 P/Share
|
|
Apr 01
2023
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
206
+1.2%
|
$55,002
$267.49 P/Share
|
|
Apr 01
2023
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
206
+3.85%
|
$55,002
$267.49 P/Share
|
|
Apr 01
2023
|
Marc Russo EVP, Health Plans |
SELL
Payment of exercise price or tax liability
|
Direct |
2,179
-5.21%
|
$581,793
$267.49 P/Share
|
|
Apr 01
2023
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
206
+3.42%
|
$55,002
$267.49 P/Share
|
|
Apr 01
2023
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
206
+0.98%
|
$55,002
$267.49 P/Share
|
|
Mar 03
2023
|
Daniel Cooperman Director |
SELL
Open market or private sale
|
Direct |
5,000
-50.28%
|
$1,380,000
$276.77 P/Share
|
|
Mar 03
2023
|
Daniel Cooperman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+33.46%
|
$165,000
$33.02 P/Share
|
|
Mar 01
2023
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,699
-8.01%
|
$3,466,827
$273.8 P/Share
|
|
Mar 01
2023
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,967
+12.32%
|
$6,542,991
$273.8 P/Share
|
|
Mar 01
2023
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,708
-12.81%
|
$3,742,284
$273.44 P/Share
|